SlideShare a Scribd company logo
1 of 19
Presentation By:
Abhishek Gupta
Jyoti Sawana
 Started by ‘Ran’bir Singh & Gur‘bax’
Singh in 1937.

 They sold the company to their cousin
“Mohan Singh” in 1952.

 Company went public in 1973.

 Entered the US markets in 1998, other
major countries- Brazil, Russia, China
and Europe.
 Indian Multinational Pharmaceutical
company incorporated in 1961.

 “Daiichi Sankyo” acquired a
controlling interest (50.1%) in 2008.

 Exports to 125 countries, with
manufacturing facilities available in 8
of them.
 Former CEO, Malvinder Singh and his
brother sold their share of Ranbaxy for $2
Billion in 2008 to Daiichi- Sankyo.

 Current CEO of Ranbaxy: Mr. Arun Sawhney.

 Ranbaxy generated a revenue of $2 Billion in
2012, EBITDA- $290 Million in 2012.

 Listed in the NSE(RANBAXY) and the
BSE(500359).
 Currently Ranbaxy has 11 plants in India:
Mohali, Punjab
Toansa, Punjab
Dewas, MP
Paonta Sahib, HP
Okhla, New Delhi
Jejuri, Maharashtra
Ponda, Goa
Paonta Sahib, HP(2nd Plant)
Ghirongi, MP
Mohali, Punjab(2nd Plant)
Baddi, HP
 Apart from these, Ranbaxy has a number
of externally hired laboratories in India as
well.
 WHISTLE BLOWERS:- In 200405, Dinesh Thakur and Rajinder
Kumar blew the whistle on Ranbaxy’s
fabrication of drug test reports.
 As a result, in 2008, Ranbaxy
Laboratories ltd. was issued 2 warning
letters by the FDA and an import alert
on 2 Indian manufacturing plants
(Dewas & Poanta Sahib).
 Later the same year, the USFDA
banned all products from the
Toansa, Poanta Sahib plants.
 February 2012, three batches of the
proton-pump inhibitor
Pantoprazole were recalled in the
Netherlands due to the presence of
impurities.

 November 2012, Ranbaxy halted
production and recalled forty-one lots
of Atorvastatin due to glass particles
being found in some bottles.
 In May 2013, the company pleaded
guilty to felony charges related to drug
safety and agreed to pay $500 million
in civil and criminal fines under the
settlement agreement with the US
department of justice.

 As per the Whistleblower
agreement, Dinesh Thakur received
$48.1 million for his efforts in bringing
Ranbaxy to justice.
 September 2013, further problems
were reported, including apparent
human hair in a tablet, oil spots on
other tablets, toilet facilities without
running water, and a failure to instruct
employees to wash their hands after
using the toilet.
 Due to the above, Ranbaxy is
prohibited from manufacturing FDAregulated drugs at the Mohali facility
until the company complies with U.S.
drug manufacturing requirements.
 In January 2014, the US-FDA, in one of
its inspection found irregularities from
the data from the Toansa plant.

 The US-FDA banned all the products
from this plant as well.

 “Our inspection of the quality control
analytical and microbiology
laboratories found the facility to be in
significant disrepair,” - US FDA
inspector.
 Ranbaxy’s Toansa factory, with its
inception in 1986, is one of the oldest
active pharmaceutical ingredient (API)
manufacturing facilities in the country.
Till the latest US ban was imposed on
the unit, it was catering to over 70 per
cent of Ranbaxy’s captive requirement
for API or raw material used in
medicine formulations.

 US FDA Form 483 highlighted eight
serious deviations in Ranbaxy’s Toansa
factory. These included presence of
flies through broken windows, building
up of melting ice in refrigerator where
drug samples were stored, nonmaintenance of analytical
instruments, etc.
 "While we continue to assess the
overall business impact on all aspects
in our value chain, our direct sales
impact because of the Toansa facility
issue will be limited." - Arun Sawhney
(CEO, Ranbaxy)
 "What we know publicly is that the
company has spent a lot of money
upgrading its facilities, which is a part
of the solution, The bigger issue is
changing the culture of the
company, which will take inspired
leadership, not just external
consultants.” – Dinesh Thakur(Former
Employee, Whistleblower)
 “This is a complete cover-up act by the
management. The management must
look for the right kind of solutions to
address the problem, instead of
shifting the blame on employees.” a
company employee told Business
Standard, on conditions of anonymity.
 “We are supporting and focusing on
this action as a matter of high
priority, For further approach to solve a
series of problems, we think we need a
comprehensive policy after this. We
want to go back and prepare a more
aggressive, more drastic response.”
Daiichi Sankyo Senior Executive Officer
Manabu Sakai
 CBS News
 Fox News
 CNN
 The Economic Times
 Business-Standard
 Fortune Magazine- Investigative article
“Dirty Medicine”
 Wikipedia
 Reuters
 Money Control.com
 BSE
 Ranbaxy website
 DD News- “The Big Picture”
Any Questions?
Thank You!

More Related Content

What's hot (20)

Nirav modi scam presentation
Nirav modi scam presentationNirav modi scam presentation
Nirav modi scam presentation
 
Ethics PNB SCAM
Ethics PNB SCAMEthics PNB SCAM
Ethics PNB SCAM
 
Sahara case
Sahara caseSahara case
Sahara case
 
Punjab National Bank- Nirav Modi Fraud
Punjab National Bank- Nirav Modi Fraud Punjab National Bank- Nirav Modi Fraud
Punjab National Bank- Nirav Modi Fraud
 
The sahara scam
The sahara scamThe sahara scam
The sahara scam
 
Sahara scam power point
Sahara scam power pointSahara scam power point
Sahara scam power point
 
Satyam Scam
Satyam ScamSatyam Scam
Satyam Scam
 
Saharascam
SaharascamSaharascam
Saharascam
 
PUNJAB NATIONAL BANK SCAM (NIRAV MODI)
PUNJAB NATIONAL BANK SCAM (NIRAV MODI)PUNJAB NATIONAL BANK SCAM (NIRAV MODI)
PUNJAB NATIONAL BANK SCAM (NIRAV MODI)
 
Pnb scam
Pnb scamPnb scam
Pnb scam
 
Anand-rathi
Anand-rathiAnand-rathi
Anand-rathi
 
Zydus final ppt
Zydus final pptZydus final ppt
Zydus final ppt
 
Sun pharma
Sun pharmaSun pharma
Sun pharma
 
Satyam Scandal
Satyam ScandalSatyam Scandal
Satyam Scandal
 
Cipla final
Cipla finalCipla final
Cipla final
 
Satyam scam
Satyam scamSatyam scam
Satyam scam
 
Ranbaxy daiichi
Ranbaxy  daiichiRanbaxy  daiichi
Ranbaxy daiichi
 
Sahara India Pariwar Investor Fraud Case
Sahara India Pariwar Investor Fraud CaseSahara India Pariwar Investor Fraud Case
Sahara India Pariwar Investor Fraud Case
 
PNB scam
PNB scamPNB scam
PNB scam
 
Scam in india
Scam in indiaScam in india
Scam in india
 

Similar to Ranbaxy crisis

Ranbaxy global strategy for growth
Ranbaxy   global strategy for growthRanbaxy   global strategy for growth
Ranbaxy global strategy for growthVirendra Shukla
 
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
 
Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011david_singer
 
Ranbaxycompanyprofile
Ranbaxycompanyprofile Ranbaxycompanyprofile
Ranbaxycompanyprofile bhawna allagh
 
Indian pharmaceuticals-industry (1)
Indian pharmaceuticals-industry (1)Indian pharmaceuticals-industry (1)
Indian pharmaceuticals-industry (1)lalisharma
 
Sun pharmaceutical ( international marketing ) term paper
Sun pharmaceutical ( international marketing ) term paperSun pharmaceutical ( international marketing ) term paper
Sun pharmaceutical ( international marketing ) term paperAniruddha Vashishtha
 
Presentation1.pptxdilip shanghvi
Presentation1.pptxdilip shanghviPresentation1.pptxdilip shanghvi
Presentation1.pptxdilip shanghviKaran Patel
 
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing Facility
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing FacilityGlobal Supply Chain in RANBAXY Paonta Sahib Manufacturing Facility
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing FacilityAnkur Srivastava
 
Global supply chain in ranbaxy paonta sahib manufacturing facility
Global supply chain in ranbaxy paonta sahib manufacturing facilityGlobal supply chain in ranbaxy paonta sahib manufacturing facility
Global supply chain in ranbaxy paonta sahib manufacturing facilityAnkur Srivastava
 
Sanmour Pharma - Ram Gulwady CV
Sanmour Pharma - Ram Gulwady CVSanmour Pharma - Ram Gulwady CV
Sanmour Pharma - Ram Gulwady CVAmogh Gulwady
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
 
Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014Sathish Vemula
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in indiaSahil Khanna
 
Presented by buddhabhushan reddy.new
Presented by  buddhabhushan reddy.newPresented by  buddhabhushan reddy.new
Presented by buddhabhushan reddy.newBUDDHABHUSHAN DONGRE
 
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaPresent Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaMadhuraNewrekar
 

Similar to Ranbaxy crisis (20)

Ranbaxy global strategy for growth
Ranbaxy   global strategy for growthRanbaxy   global strategy for growth
Ranbaxy global strategy for growth
 
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...
 
Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011
 
Ranbaxycompanyprofile
Ranbaxycompanyprofile Ranbaxycompanyprofile
Ranbaxycompanyprofile
 
Indian pharmaceuticals-industry (1)
Indian pharmaceuticals-industry (1)Indian pharmaceuticals-industry (1)
Indian pharmaceuticals-industry (1)
 
Sun pharmaceutical ( international marketing ) term paper
Sun pharmaceutical ( international marketing ) term paperSun pharmaceutical ( international marketing ) term paper
Sun pharmaceutical ( international marketing ) term paper
 
Presentation1.pptxdilip shanghvi
Presentation1.pptxdilip shanghviPresentation1.pptxdilip shanghvi
Presentation1.pptxdilip shanghvi
 
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing Facility
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing FacilityGlobal Supply Chain in RANBAXY Paonta Sahib Manufacturing Facility
Global Supply Chain in RANBAXY Paonta Sahib Manufacturing Facility
 
Global supply chain in ranbaxy paonta sahib manufacturing facility
Global supply chain in ranbaxy paonta sahib manufacturing facilityGlobal supply chain in ranbaxy paonta sahib manufacturing facility
Global supply chain in ranbaxy paonta sahib manufacturing facility
 
Sanmour Pharma - Ram Gulwady CV
Sanmour Pharma - Ram Gulwady CVSanmour Pharma - Ram Gulwady CV
Sanmour Pharma - Ram Gulwady CV
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
 
Ranbaxy pvt
Ranbaxy pvtRanbaxy pvt
Ranbaxy pvt
 
Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014
 
1
11
1
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in india
 
Presented by buddhabhushan reddy.new
Presented by  buddhabhushan reddy.newPresented by  buddhabhushan reddy.new
Presented by buddhabhushan reddy.new
 
PRITI.pptx
PRITI.pptxPRITI.pptx
PRITI.pptx
 
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in IndiaPresent Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in India
 
Dr reddy
Dr reddyDr reddy
Dr reddy
 
Pharma marketing
Pharma marketingPharma marketing
Pharma marketing
 

More from Abhishek Gupta

Facebook and Security Settings Report
Facebook and Security Settings ReportFacebook and Security Settings Report
Facebook and Security Settings ReportAbhishek Gupta
 
Wireless bomb disposal robot ppt
Wireless bomb disposal robot pptWireless bomb disposal robot ppt
Wireless bomb disposal robot pptAbhishek Gupta
 
Facebook and security settings settings
Facebook and security settings settingsFacebook and security settings settings
Facebook and security settings settingsAbhishek Gupta
 
Wireless Bomb Disposal Robot
Wireless Bomb Disposal RobotWireless Bomb Disposal Robot
Wireless Bomb Disposal RobotAbhishek Gupta
 
Wireless Bomb Disposal Robot
Wireless Bomb Disposal RobotWireless Bomb Disposal Robot
Wireless Bomb Disposal RobotAbhishek Gupta
 
Millipede presentation
Millipede presentationMillipede presentation
Millipede presentationAbhishek Gupta
 

More from Abhishek Gupta (6)

Facebook and Security Settings Report
Facebook and Security Settings ReportFacebook and Security Settings Report
Facebook and Security Settings Report
 
Wireless bomb disposal robot ppt
Wireless bomb disposal robot pptWireless bomb disposal robot ppt
Wireless bomb disposal robot ppt
 
Facebook and security settings settings
Facebook and security settings settingsFacebook and security settings settings
Facebook and security settings settings
 
Wireless Bomb Disposal Robot
Wireless Bomb Disposal RobotWireless Bomb Disposal Robot
Wireless Bomb Disposal Robot
 
Wireless Bomb Disposal Robot
Wireless Bomb Disposal RobotWireless Bomb Disposal Robot
Wireless Bomb Disposal Robot
 
Millipede presentation
Millipede presentationMillipede presentation
Millipede presentation
 

Recently uploaded

Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 
Chapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditChapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditNhtLNguyn9
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSendBig4
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environmentelijahj01012
 
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...ssuserf63bd7
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Servicecallgirls2057
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckHajeJanKamps
 
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...ssuserf63bd7
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOnemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOne Monitar
 

Recently uploaded (20)

Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 
Chapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditChapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal audit
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.com
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environment
 
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
 
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptxThe Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
 
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
Horngren’s Financial & Managerial Accounting, 7th edition by Miller-Nobles so...
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOnemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
 
Call Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North GoaCall Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North Goa
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 

Ranbaxy crisis

  • 2.  Started by ‘Ran’bir Singh & Gur‘bax’ Singh in 1937.  They sold the company to their cousin “Mohan Singh” in 1952.  Company went public in 1973.  Entered the US markets in 1998, other major countries- Brazil, Russia, China and Europe.
  • 3.  Indian Multinational Pharmaceutical company incorporated in 1961.  “Daiichi Sankyo” acquired a controlling interest (50.1%) in 2008.  Exports to 125 countries, with manufacturing facilities available in 8 of them.
  • 4.  Former CEO, Malvinder Singh and his brother sold their share of Ranbaxy for $2 Billion in 2008 to Daiichi- Sankyo.  Current CEO of Ranbaxy: Mr. Arun Sawhney.  Ranbaxy generated a revenue of $2 Billion in 2012, EBITDA- $290 Million in 2012.  Listed in the NSE(RANBAXY) and the BSE(500359).
  • 5.  Currently Ranbaxy has 11 plants in India: Mohali, Punjab Toansa, Punjab Dewas, MP Paonta Sahib, HP Okhla, New Delhi Jejuri, Maharashtra Ponda, Goa Paonta Sahib, HP(2nd Plant) Ghirongi, MP Mohali, Punjab(2nd Plant) Baddi, HP  Apart from these, Ranbaxy has a number of externally hired laboratories in India as well.
  • 6.
  • 7.  WHISTLE BLOWERS:- In 200405, Dinesh Thakur and Rajinder Kumar blew the whistle on Ranbaxy’s fabrication of drug test reports.  As a result, in 2008, Ranbaxy Laboratories ltd. was issued 2 warning letters by the FDA and an import alert on 2 Indian manufacturing plants (Dewas & Poanta Sahib).  Later the same year, the USFDA banned all products from the Toansa, Poanta Sahib plants.
  • 8.  February 2012, three batches of the proton-pump inhibitor Pantoprazole were recalled in the Netherlands due to the presence of impurities.  November 2012, Ranbaxy halted production and recalled forty-one lots of Atorvastatin due to glass particles being found in some bottles.
  • 9.  In May 2013, the company pleaded guilty to felony charges related to drug safety and agreed to pay $500 million in civil and criminal fines under the settlement agreement with the US department of justice.  As per the Whistleblower agreement, Dinesh Thakur received $48.1 million for his efforts in bringing Ranbaxy to justice.
  • 10.  September 2013, further problems were reported, including apparent human hair in a tablet, oil spots on other tablets, toilet facilities without running water, and a failure to instruct employees to wash their hands after using the toilet.  Due to the above, Ranbaxy is prohibited from manufacturing FDAregulated drugs at the Mohali facility until the company complies with U.S. drug manufacturing requirements.
  • 11.
  • 12.  In January 2014, the US-FDA, in one of its inspection found irregularities from the data from the Toansa plant.  The US-FDA banned all the products from this plant as well.  “Our inspection of the quality control analytical and microbiology laboratories found the facility to be in significant disrepair,” - US FDA inspector.
  • 13.  Ranbaxy’s Toansa factory, with its inception in 1986, is one of the oldest active pharmaceutical ingredient (API) manufacturing facilities in the country. Till the latest US ban was imposed on the unit, it was catering to over 70 per cent of Ranbaxy’s captive requirement for API or raw material used in medicine formulations.  US FDA Form 483 highlighted eight serious deviations in Ranbaxy’s Toansa factory. These included presence of flies through broken windows, building up of melting ice in refrigerator where drug samples were stored, nonmaintenance of analytical instruments, etc.
  • 14.
  • 15.  "While we continue to assess the overall business impact on all aspects in our value chain, our direct sales impact because of the Toansa facility issue will be limited." - Arun Sawhney (CEO, Ranbaxy)  "What we know publicly is that the company has spent a lot of money upgrading its facilities, which is a part of the solution, The bigger issue is changing the culture of the company, which will take inspired leadership, not just external consultants.” – Dinesh Thakur(Former Employee, Whistleblower)
  • 16.  “This is a complete cover-up act by the management. The management must look for the right kind of solutions to address the problem, instead of shifting the blame on employees.” a company employee told Business Standard, on conditions of anonymity.  “We are supporting and focusing on this action as a matter of high priority, For further approach to solve a series of problems, we think we need a comprehensive policy after this. We want to go back and prepare a more aggressive, more drastic response.” Daiichi Sankyo Senior Executive Officer Manabu Sakai
  • 17.  CBS News  Fox News  CNN  The Economic Times  Business-Standard  Fortune Magazine- Investigative article “Dirty Medicine”  Wikipedia  Reuters  Money Control.com  BSE  Ranbaxy website  DD News- “The Big Picture”